¸ð½Ã´Â±Û ÇÁ·Î±×·¥ ÃÊ·ÏÁ¢¼ö »çÀüµî·Ï ¹ßÇ¥ÀÚ ¾È³» ¼ö»óÀÚ ¾È³» Çà»çÀå¾È³» ¼÷¹Ú¾È³» Ȩ
 ÀϹݿ¬Á¦ ¹ßÇ¥ ¾È³»

  1. ¹ßÇ¥½Ã°£ ¹× ¹ßÇ¥Àå¼Ò : Çмú´ëȸ ȨÆäÀÌÁö ¡®¹ßÇ¥ÀÚ ¾È³»¡¯¿¡¼­ È®ÀÎ
  2. ¹ßÇ¥½½¶óÀ̵å Á¦Ãâ : 2015³â 9¿ù 14ÀÏ(¿ù)±îÁö office@ksog.org·Î Á¦Ãâ(PPTÆÄÀÏ)
    ¹ßÇ¥½½¶óÀ̵å´Â »çÀü¿¡ ¹Ýµå½Ã Á¦ÃâÇÏ¿©¾ß Çϸç, ¹ßÇ¥ ´çÀÏ ¼öÁ¤µÈ ÆÄÀÏ·Î ±³Ã¼°¡´ÉÇÔ
    (¹ßÇ¥½½¶óÀÌµå ¹ÌÁ¦Ãâ½Ã ¹ßÇ¥Æ÷±â·Î °£ÁÖÇÔ)
  3. ¹ßÇ¥°ü·Ã À¯ÀÇ»çÇ×
    - ½½¶óÀ̵å´Â 15¸Å À̳», 1Àå´ç 10ÁÙ À̳»·Î Á¦ÀÛÀ» ±ÇÀåÇÔ
    - ÁöÁ¤µÈ ¹ßÇ¥½Ã°£(7ºÐ ¹ßÇ¥, 3ºÐ ÁúÀÇÀÀ´ä ÃÑ 10ºÐ)À» ÁؼöÇÏ¿©¾ß ÇÔ
    - ¹ßÇ¥´çÀÏ 4Ãþ Preview Room¿¡¼­ ÃÖÁ¾ ¹ßÇ¥ÆÄÀÏÀ» È®ÀÎÇϰųª ¼öÁ¤ÆÄÀÏÀ» Á¦Ãâ°¡´É
    (»çÀü Á¦ÃâÀÚ·á¿¡¼­ º¯°æÀÌ ¾ø´õ¶óµµ È®ÀÎÇÏ¿©¾ß Çϸç, ƯÈ÷ µ¿¿µ»óÀ» »ç¿ëÇÏ´Â °æ¿ì¿¡´Â È®ÀÎÇʼö)
¸ðüžÆÀÇÇР  /    »ý½Ä³»ºÐºñÇР  /    ºÎÀÎÁ¾¾çÇР  /    ÀϹݺÎÀΰúÇÐ
ÀϹݿ¬Á¦ : ¸ðüžÆÀÇÇÐ - ÀϽà : 2015³â 9¿ù 18ÀÏ (±Ý)
- Àå¼Ò : ¿¡¸Þ¶öµåȦ A[3F]
OB1-OB4 (08:20~09:00) ÁÂÀå : ±èÀ±ÇÏ(Àü³²ÀÇ´ë)
OB108:20~08:30 õÁÖ¿µ
°¡Å縯ÀÇ´ë ¼­¿ï¼º¸ðº´¿ø »êºÎÀΰú
Assessment factors for successful medical treatment for missed abortion
OB208:30~08:40 °æ±Ô»ó
ÃæºÏ´ëÇб³º´¿ø »êºÎÀΰú
Expression of the two-pore domain potassium channel TASK2 in human myometrium
OB308:40~08:50 ½ÅÀ¯Á¤
Quantitative Fluorescent PCR for rapid prenatal diagnosis of fetal aneuploidies in chorionic villous sampling in the Korean population
OB408:50~09:00 ±è¿µÁÖ
ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐºÎ¼Ó ¸ñµ¿º´¿ø »êºÎÀΰú
A comprehensive microarray-based DNA methylation profiling in maternal blood of preterm birth
OB5-OB8 (09:00~09:40) ÁÂÀå : ½ÅÁ¾Ã¶(°¡Å縯ÀÇ´ë)
OB509:00~09:10 ÁøÇý¹Ì
°í·ÁÀÇ´ë ±¸·Îº´¿ø »êºÎÀΰú
Analysis of Tensile-strength and Biochemistry of human chorioamnionic membrane at term and human chorioamnionic membranes in inflammatory model
OB609:10~09:20 ÀÌÁØÈ£
¼­¿ï´ëÇб³º´¿ø »êºÎÀΰú
The efficacy of a new anti-microbial combination in patients with preterm premature rupture of membranes
OB709:20~09:30 ÀÌ¿µÁÖ
ºÎ»ê´ëÇб³º´¿ø »êºÎÀΰú
Cross-talk between steroid receptor coactivators and estrogen receptors during gestation in the human placenta
OB809:30~09:40 Á¤°æÈñ
Â÷ÀÇ°úÇдëÇб³ °­³²Â÷º´¿ø »êºÎÀΰú
Comparative transcriptome analysis of cell-free fetal RNA from amniotic fluid and RNA from amniocytes in uncomplicated pregnancies
OB9-OB12 (09:40~10:20) ÁÂÀå : ±è ¾Ï(¿ï»êÀÇ´ë)
OB909:40~09:50 °ûµ¿¿í
Quantification and application of potential epigenetic markers in maternal plasma of pregnancies with hypertensive disorders
OB1009:50~10:00 Á¤¼±È­
°í·ÁÀÇ´ë ¾È»êº´¿ø »êºÎÀΰú
Effects of Antenatal Magnesium Sulfate Exposure on Oxygen Support in Preterm Neonates
OB1110:00~10:10 ¾ç¼±Çý
¼­¿ï´ëÇб³º´¿ø »êºÎÀΰú
Neonatal survival and morbidity advantages of delayed interval delivery
OB1210:10~10:20 ¹Ú¼±Èñ
¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú
Delta Neutrophil Index as a Predictive marker of Chorioamnionitis in preterm premature rupture of membranes
OB13-OB17 (10:50~11:40) ÁÂÀå : ±è±¤ÁØ(Áß¾ÓÀÇ´ë)
OB1310:50~11:00 À̽¹Ì
¼­¿ïƯº°½Ã º¸¶ó¸Åº´¿ø »êºÎÀΰú
žư£ ¼ºÀåºÒÀÏÄ¡¸¦ º¸ÀÌ´Â ÀÌÀ¶¸ð¸·¼º ½Öžƿ¡¼­ ¾ç¼ö ¹× Á¦´ëÇ÷ ³» ¾ÆµðÆ÷Ä«ÀÎÀÇ ³óµµ ºñ±³
OB1411:00~11:10 À±Áö¼±
¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú
HbA1c for diagnosis and prognosis of gestational diabetes mellitus
OB1511:10~11:20 ±èÁöÇý
Â÷ÀÇ°úÇдëÇб³ °­³²Â÷º´¿ø »êºÎÀΰú
Á¤»óÀӽſ¡¼­ ÀÓ½ÅÃʱ⠽ÅüÁú·®Áö¼ö, ÀӽŠÁ¦ 3ºÐ±âÀÇ ¸ðüÀÇ Ã¼Áß Áõ°¡¿Í ÁöÁú ¼ººÐÀÌ ÀÚ³àÀÇ Ãâ»ý ½Ã üÁß¿¡ ¹ÌÄ¡´Â ¿µÇâ°ú »ó°ü°ü°è¿¡ ´ëÇÑ ¿¬±¸
OB1611:20~11:30 ±èÈñ¼±
°Ç±¹´ëÇб³º´¿ø »êºÎÀΰú
The relationship between maternal and fetal 25-hydroxyvitamin D in pregnant women with gestational diabetes mellitus
OB1711:30~11:40 ÀÌÁ¾¹Î
ÀÌÈ­¿©¼ºº´¿ø
The Association Hip Abductor Strengthening Exercise and Vaginal delivery
OB18-OB21 (11:40~12:20) ÁÂÀå : ¼ÕÀμ÷(°Ç±¹ÀÇ´ë)
OB1811:40~11:50 ±èÁö¿¹
¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø »êºÎÀΰú
Abnormal vaginal colonization by gram negative bacteria is significantly higher in pregnancy with infertility treatment compared to natural pregnancy
OB1911:50~12:00 ±èÀÇÇõ
±¹¹Î°Ç°­º¸Çè°ø´Ü Àϻ꺴¿ø »êºÎÀΰú
The role of progesterone receptor membrane component 1 (PGRMC1) on cytokine inflammation induced neutrophil gelatinase-associated lipocalin (NGAL) mRNA expression in a cytotrophoblast cell line
OB2012:00~12:10 Á¤Àº¿µ
¼­¿ï´ëÇб³ ºÐ´çº´¿ø »êºÎÀΰú
Measurement of interleukin-8 in cervicovaginal fluid for the prediction of intraamniotic infection in women with preterm labor: a comparison with amniotic fluid samples
OB2112:10~12:20 ÀÌ°èÈ­
¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ
Genetic Variants Associated with Ritodrine-induced Pulmonary Edema
OB22-OB24 (13:40~14:10) ÁÂÀå : À̱ٿµ(ÇѸ²ÀÇ´ë)
OB2213:40~13:50 ÃÖ¼ö¶õ
ÀÎÇÏ´ëÇб³º´¿ø »êºÎÀΰú
Characterization of Secretory leukocyte protease inhibitor and Interleukin1-beta expression in term fetal membranes
OB2313:50~14:00 ¹ÚÁö±Ç
°æ»ó´ëÇб³º´¿ø »êºÎÀΰú
Modified Shirodkar Procedure in Emergency Cervical Cerclage
OB2414:00~14:10 ¹èÁø°ï
°è¸íÀÇ´ë µ¿»êÀÇ·á¿ø »êºÎÀΰú
Outcome of laparoscopic transabdominal cervicoisthmic cerclage during pregnancy
ÀϹݿ¬Á¦ : ¸ðüžÆÀÇÇÐ - ÀϽà : 2015³â 9¿ù 18ÀÏ (±Ý)
- Àå¼Ò : ´ÙÀ̾ƸóµåȦ[3F]
OB25-OB27 (14:10~14:40) ÁÂÀå : ÀüÁ¾°ü(¼­¿ïÀÇ´ë)
OB2514:10~14:20 È«´öÈ£
ÃæºÏ´ëÇб³º´¿ø »êºÎÀΰú
Àü¹æ ÀüÄ¡ÅÂ¹Ý Àӽſ¡¼­ ÅÂ¹Ý Àý°³¸¦ ÅëÇÑ Á¦¿ÕÀý°³ ºÐ¸¸ÀÇ ¾ÈÁ¤¼º
OB2614:20~14:30 ¼ÕÁÖÇõ
¾ÆÁÖ´ëÇб³º´¿ø »êºÎÀΰú
Perinatal outcomes in fetal growth restriction according to types of hypertensive disorders in pregnancy
OB2714:30~14:40 ÀÌÀ¯Á¤
°¡ÃµÀÇ´ë ±æº´¿ø »êºÎÀΰú
ºÐ¸¸±âÀÚ±ÃÀûÃâ¼úÀ» ½ÃÇà ¹ÞÀº ȯÀÚ¿¡¼­ Ãâ»ê·Â¿¡ µû¸¥ ÀÓ»óÀû Ư¡ÀÇ ºñ±³ Clinical characteristics in parturient performing peripartum hysterectomy based on numbers of parity.
OB28-OB30 (14:40~15:10) ÁÂÀå : È«±â¿¬(¿ø±¤ÀÇ´ë)
OB2814:40~14:50 À̳ª¶ó
¼­¿ï´ëÇб³º´¿ø »êºÎÀΰú
Postnatal courses of antenatally diagnosed congenital lung lesions
OB2914:50~15:00 °ø¼ö°æ
°¡ÃµÀÇ´ë ±æº´¿ø »êºÎÀΰú
Perinatal outcomes of idiopathic polyhydramnios: a relationship between the degree of polyhydramnios and the risk of adverse outcomes
OB3015:00~15:10 ÀÌ¿µÁÖ
ºÎ»ê´ëÇб³º´¿ø »êºÎÀΰú
Amniotic fluid index and single deepest pocket : Parameter of predictive delivery latency in preterm premature rupture of membranes